Articles / Semaglutide cuts CV risk in overweight with no T2D
Autism Spectrum Disorder in Children
Early Menopause
Donanemab – A GP Guide to Anti-Amyloid Therapies
LDL and Cardiovascular Disease
Within the next 12 months
Within the next 3 years
Within the next 5 years
Within the next 10 years
More than 10 years
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease